May 15, 2026, 11:00 AM EDT
This webinar explores recent advancements in crystal screening and characterization for pharmaceutical development. In the first segment, researchers from NGK Corporation outline a new crystal polymorphism screening approach that utilizes infrared radiation technology to enhance the detection of previously unidentified crystalline forms. Experimental case studies will illustrate how this method can support more reliable and efficient drug development. In the second segment, Professor Etsuo Yonemochi from the International University of Health and Welfare will discuss the relationship between crystallization conditions and crystal morphology, examining how these factors influence properties such as dissolution, wettability, and manufacturability. His presentation will also cover the use of molecular simulations to assess formulation-related characteristics.
This webinar will provide:
- Introduction of NGK’s novel crystal polymorphism screening service, which applies proprietary infrared radiation technology to enhance the discovery of previously unknown crystalline forms.
- Practical experimental case studies demonstrating how infrared based screening can complement conventional polymorphism screening approaches and support more robust drug development.
- Fundamental understanding of pharmaceutical crystal morphology, including how crystallization conditions influence crystal habit and surface growth behavior.
- Insights into the impact of crystal morphology on formulation properties, such as wettability, dissolution behavior, flowability, and tabletability during pharmaceutical manufacturing.
- Advanced evaluation approaches using molecular simulations, illustrating how crystal structure data can be applied to predict and assess formulation relevant physicochemical properties.
Who should attend:
- Researchers engaged in physical properties research
- Analytical researchers
- Process researchers
- Scientists and professionals in drug discovery
Offered Free by: NGK | American Pharmaceutical Review
See All Resources from: NGK | American Pharmaceutical Review
